These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 973959)

  • 1. beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.
    Aellig WH
    Br J Clin Pharmacol; 1976 Apr; 3(2):251-7. PubMed ID: 973959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

  • 3. Experiments with pindolol (Visken) in healthy volunteers.
    Aellig WH
    Med J Aust; 1977 Sep; 2(SP2):8-11. PubMed ID: 927284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effect of pindolol and propranolol on heart rate after acute and chronic administration.
    Finch MB; O'Connor PC; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1983 Apr; 15(4):431-4. PubMed ID: 6849778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity.
    Aellig WH
    Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
    O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of propranolol and pindolol on plasma ANP levels in humans at rest and during exercise.
    Bouissou P; Galen FX; Richalet JP; Lartigue M; Devaux F; Dubray C; Atlan G
    Am J Physiol; 1989 Aug; 257(2 Pt 2):R259-64. PubMed ID: 2527473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients.
    Chu D; Cocco G; Schweda E; Haeusler G; Strozzi C
    Eur J Clin Pharmacol; 1980 Aug; 18(2):141-6. PubMed ID: 7428794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of propranolol and pindolol on the up-regulation of lymphocytic beta adrenoceptors during acute submaximal physical exercise. A placebo-controlled double-blind study.
    Mäki T; Näveri H; Leinonen H; Sovijärvi A; Lewko B; Härkönen M; Kontula K
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):544-51. PubMed ID: 1691382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
    Kofi Ekue JM; Lowe DC; Shanks RG
    Br J Pharmacol; 1970 May; 38(3):546-53. PubMed ID: 4392540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levo-bunolol and propranolol: further evaluation of oral beta-blocking activity in conscious dogs.
    Commarato MA; Giardino EC; Kopia GA; Kaplan HR
    Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):205-13. PubMed ID: 327960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta blockade and intrinsic sympathomimetic activity on exercise performance.
    Ades PA; Brammell HL; Greenberg JH; Horwitz LD
    Am J Cardiol; 1984 Dec; 54(10):1337-41. PubMed ID: 6507309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the acute haemodynamic effects of propranolol and pindolol at rest and during supine exercise in man.
    Svendsen TL; Carlsen JE; Hartling O; McNair A; Trap-Jensen J
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():465s-468s. PubMed ID: 7449300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes.
    Brodde OE; Wang XL; O'Hara N; Daul A; Schiess W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S70-3. PubMed ID: 2439825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
    McGibney D; Singleton W; Silke B; Taylor SH
    Br J Clin Pharmacol; 1983 Jan; 15(1):15-9. PubMed ID: 6849739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of four beta-adrenoceptor antagonists during modest exercise on plasma ammonia and heart rate.
    Hall PE; Smith SR; Kendall MJ
    Clin Sci (Lond); 1987 Jun; 72(6):679-82. PubMed ID: 2885122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol.
    Giudicelli Y; Lacasa D; Agli B; Leneveu A
    Eur J Clin Pharmacol; 1984; 26(1):7-12. PubMed ID: 6325205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.